Diabetes mellitus related enzymes

Diabetes mellitus related enzymes refer to a diverse group of enzymatic proteins that play critical roles in the regulation of blood glucose and the pathogenesis of metabolic disorders. This category encompasses intestinal enzymes such as alpha-glucosidase and alpha-amylase, which facilitate the digestion of complex carbohydrates into simple sugars, and dipeptidyl peptidase 4 (DPP-4), which is responsible for the rapid degradation of insulinotropic incretin hormones like glucagon-like peptide-1 (GLP-1) (BOC Sciences, 2024; ResearchGate, 2021). Additionally, intracellular targets such as protein tyrosine phosphatase 1B (PTP1B) and 11-beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) are included, as they negatively regulate insulin signaling or promote local glucocorticoid production, respectively (PMC8922258, 2023; NIH, 2021). Pharmacological agents targeting these enzymes, such as acarbose or sitagliptin, aim to restore glycemic control by delaying glucose absorption or enhancing endogenous insulin secretion (PubMed, 2021). Because this term refers to a collection of distinct molecules rather than a single specific target, therapeutic strategies and safety profiles vary significantly across the group.

Other names

Anti-diabetic enzymesGlucose-regulating enzymesTarget enzymes for diabetes treatmentCarbohydrate-metabolizing enzymes

Inhibition of carbohydrate-hydrolyzing enzymes to slow glucose absorption, inhibition of DPP-4 to prolong incretin activity, and modulation of regulatory enzymes to enhance insulin sensitivity or reduce hepatic glucose production.